4.7 Article

Prevalence of genital, oral, and anal HPV infection among STI patients in Italy

期刊

JOURNAL OF MEDICAL VIROLOGY
卷 89, 期 6, 页码 1121-1124

出版社

WILEY
DOI: 10.1002/jmv.24746

关键词

anal HPV infection; genital HPV infection; HPV carcinogenicity; human papillomavirus (HPV); oral HPV infection

类别

向作者/读者索取更多资源

Human papillomavirus (HPV) is a carcinogenic agent responsible for tumor development in many sexually involved tissues. We present a survey on the prevalence of HPV infection in a risk population for sexually transmitted infections (STIs). The studied population was formed by 125 STI clinic attendees, who took part in a screening program on STIs. To be included in the study, the patients had to show no overt clinical signs of HPV infection. Genital (cervical in women, urethral in men), anal, and oral samples were collected with ThinPrep liquid based cytology preparation system. Overall, of the screened population, 56% proved positive for genital HPV, 37% for oral HPV, and 42% for anal HPV infection. Our data indicate that in STI patients, HPV infection is more prevalent, than previously estimated. Further studies are needed to better understand the epidemiological burden of HPV in sexually involved tissues, especially in the oral mucosa.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Dermatology

Sudden onset of vitiligo after COVID-19 vaccine

Giulia Ciccarese, Francesco Drago, Samuele Boldrin, Matilde Pattaro, Aurora Parodi

DERMATOLOGIC THERAPY (2022)

Article Dermatology

5-Fluorouracil 0.5%/salicylic acid 10% solution in the treatment of ano-genital warts

Giulia Ciccarese, Aurora Parodi, Francesco Drago

Summary: This study investigated the efficacy of 5-fluorouracil 0.5%/salicylic acid 10% solution (5FU/SAsol) in the treatment of ano-genital warts (AGWs). The results showed that 88% of patients benefited from the treatment at 3 months and 94% at 6 months. 5FU/SAsol was well tolerated with minimal adverse events. The clearance rate after 3 months of treatment was comparable to other commonly used modalities.

DERMATOLOGIC THERAPY (2022)

Letter Infectious Diseases

Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination

Francesco Drago, Francesco Broccolo, Giulia Ciccarese

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Letter Virology

Pityriasis rosea during COVID-19: Pathogenesis, diagnosis, and treatment

Giulia Ciccarese, Francesco Drago, Eugenio Marinaro, Aurora Parodi

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Virology

Oncoviruses and melanomas: A retrospective study and literature review

Giulia Ciccarese, Francesco Drago, Francesco Broccolo, Angela Pastorino, Laura Pizzatti, Laura Atzori, Luca Pilloni, Davide Santinelli, Alice Urbani, Aurora Parodi, Carlo Tomasini, Franco Rongioletti

Summary: This study investigated the association between human oncoviruses and melanoma. The detection rate of oncoviruses (HPV, EBV, and herpesvirus 8DNA) was found to be higher in mucosal and ocular melanomas compared to cutaneous melanomas. This suggests that oncoviruses may act as cofactors in the development of certain types of melanoma.

JOURNAL OF MEDICAL VIROLOGY (2023)

Letter Dermatology

Comment on 'Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions'

Giulia Ciccarese, Francesco Broccolo, Aurora Parodi, Francesco Drago

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Immunology

Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV

Laura Labate, Giorgia Brucci, Giulia Ciccarese, Bianca Bruzzone, Valentina Ricucci, Federica Stefanelli, Emanuele Delfino, Lucia Taramasso, Matteo Bassetti, Antonio Di Biagio

Summary: A 25-year-old Brazilian man with concurrent diagnoses of acute HIV infection, primary syphilis, and monkeypox infection with a nasal lesion was successfully treated with intravenous cidofovir.

INTERNATIONAL JOURNAL OF STD & AIDS (2023)

Letter Dermatology

Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: A multicentre study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases

Andrea Carugno, Michele Parietti, Giulia Ciccarese, Anna Campanati, Federico Diotallevi, Laura Atzori, Riccardo Balestri, Stefano Caccavale, Francesco Bellinato, Simone Vasilij Benatti, Serena Venturelli, Pamela Vezzoli, Paolo Sena, Manuela Papini

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Letter Dermatology

Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?

Giulia Ciccarese, Mario Mastrolonardo, Gaetano Serviddio, Francesco Drago

JOURNAL OF COSMETIC DERMATOLOGY (2023)

Letter Public, Environmental & Occupational Health

Two cases of Monkeypox virus infection without detectable cutaneous/mucosal lesions

Giulia Ciccarese, Giorgia Brucci, Antonio Di Biagio, Francesco Drago, Matilde Ogliastro, Bruno Caccianotti, Sergio Lo Caputo, Teresa Santantonio, Gaetano Serviddio

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2023)

Article Medicine, General & Internal

Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores

Astrid Herzum, Corrado Occella, Lodovica Gariazzo, Carlotta Pastorino, Gianmaria Viglizzo

Summary: Corticophobia, the fear of using topical corticosteroids, is becoming a more prevalent issue in industrialized countries, despite the proven safety of these medications for treating atopic dermatitis. This study found that factors such as milder or moderate disease severity, older age of patients, earlier disease onset, and previous healthcare professional consultations were associated with parental corticophobia. Additionally, severe parental corticophobia was significantly associated with a higher level of parental education and a greater impact on parental quality of life. Assessing the risk factors for corticophobia is crucial for developing educational programs that address the concerns of high-risk parents, in order to alleviate unfounded fears and improve treatment adherence.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Medicine, General & Internal

Treatment of Pediatric Anogenital Warts in the Era of HPV-Vaccine: A Literature Review

Astrid Herzum, Giulia Ciccarese, Corrado Occella, Lodovica Gariazzo, Carlotta Pastorino, Ilaria Trave, Gianmaria Viglizzo

Summary: Treating anogenital warts in children is challenging, with limited approved treatments. Topical therapies, such as immunomodulating agents and cytotoxic agents, are considered safe and effective options. HPV vaccination may also have a potential therapeutic role.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Paediatric Spitzoid Neoplasms: 10-Year Retrospective Study Characterizing Histological, Clinical, Dermoscopic Presentation and FISH Test Results

Astrid Herzum, Corrado Occella, Valerio Gaetano Vellone, Lodovica Gariazzo, Carlotta Pastorino, Jacopo Ferro, Angela Sementa, Katia Mazzocco, Nadia Vercellino, Gianmaria Viglizzo

Summary: This study conducted a retrospective survey on pediatric spitzoid lesions and found that the majority of these lesions were benign, but there were also atypical and malignant lesions. Therefore, caution is needed in handling these lesions.

DIAGNOSTICS (2023)

暂无数据